Literatur
Autor ungenannt (1983) „Brustkrebs operiert: zusätzliche Chemotherapie wertlos, belastend“. Medical Tribune, S. 48, Nr. 22, 3.6.1983
Bonadonna G, et al. (1976) Combination chemotherapy as an adjuvant treatment in operable breast cancer. New Engl J Med 294:405–410
Fisher B, et al. (1975) L-PAM in the Management of Primary Breast Cancer. New Engl J Med 292:117–122
Fisher B, et al. (1983) Influence of Tumor Estrogen and Progesterone Receptor Levels and the Response to Tamoxifen and Chemotherapy in Primary Breast Cancer. J Clin Oncol 1
Sauter Ch (1983) Hat die heutige adjuvante zytostatische Therapie bei radikal operierten Mammacarcinompatientinnen versagt? Schweiz Med Wochenschr 113:414–417
Staquet M (Ed) (1972) The Design of Clinical Trials in Cancer Therapy. EORTC Publication, Brussels
Vorherr H (1983) Adjuvant Chemotherapy of Breast Cancer: Hope-Reality-Hazard. Klin Wochenschr 62:149–161
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nagel, G.A. Adjuvante Chemotherapie des Mammacarcinoms: Anhaltende Kontroverse. Klin Wochenschr 62, 145–148 (1984). https://doi.org/10.1007/BF01731636
Issue Date:
DOI: https://doi.org/10.1007/BF01731636